Correlation Between Bristol Myers and Coca Cola

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Coca Cola at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Coca Cola into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and Coca Cola FEMSA SAB, you can compare the effects of market volatilities on Bristol Myers and Coca Cola and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Coca Cola. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Coca Cola.

Diversification Opportunities for Bristol Myers and Coca Cola

-0.74

Correlation Coefficient

Bristol Myers  Coca Cola

Pay attention - limited upside

The 3 months correlation between Bristol and Coca is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Coca Cola FEMSA SAB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coca Cola FEMSA and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Coca Cola. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coca Cola FEMSA has no effect on the direction of Bristol Myers i.e., Bristol Myers and Coca Cola go up and down completely randomly.

Pair Corralation between Bristol Myers and Coca Cola

Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.28 times more return on investment than Coca Cola. However, Bristol Myers Squibb is 3.59 times less risky than Coca Cola. It trades about -0.14 of its potential returns per unit of risk. Coca Cola FEMSA SAB is currently generating about -0.13 per unit of risk. If you would invest  5,994  in Bristol Myers Squibb on October 1, 2024 and sell it today you would lose (226.00) from holding Bristol Myers Squibb or give up 3.77% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	95.24%
Values	Daily Returns

Bristol Myers Squibb  vs.  Coca Cola FEMSA SAB

Bristol Myers Squibb

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady primary indicators, Bristol Myers may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Coca Cola FEMSA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Coca Cola FEMSA SAB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pair Trading with Bristol Myers and Coca Cola

The main advantage of trading using opposite Bristol Myers and Coca Cola positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Coca Cola can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coca Cola will offset losses from the drop in Coca Cola's long position.

The idea behind Bristol Myers Squibb and Coca Cola FEMSA SAB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.